Skip to main content
Top
Published in: Psychiatric Quarterly 1/2020

01-03-2020 | Schizophrenia | Original Paper

Effects of a Psychoeducation Program for People with Schizophrenia Aimed at Increasing Subjective Well-Being and the Factors Influencing Those Effects: a Preliminary Study

Authors: Ayumi Shinozaki, Teruo Hayashi, Hitoshi Okamura

Published in: Psychiatric Quarterly | Issue 1/2020

Login to get access

Abstract

There have been no intervention studies of psychoeducation programs for schizophrenia that focus on improving subjective well-being or studies to determine the factors influencing such effects. This study aimed to examine the effects of a psychoeducation program combining traditional psychoeducation with a focus on providing knowledge and information and a new intervention to raise patients’ subjective well-being and to clarity the factors affecting the program’s efficacy. Subjects were 117 patients who participated in a psychoeducation program for schizophrenia between 2012 and 2018. In addition to comparing subjective well-being (Subjective Well-being under Neuroleptic Drug Treatment Short Form, Japanese version, SWNS-J) and attitudes towards drugs (Drug Attitude Inventory-10, DAI-10) before and after the program, basic information such as psychiatric symptoms was surveyed. The factors influencing the effects of the program were assessed with multiple regression analysis. Scores for SWNS-J subscales and total SWNS-J score increased significantly after the program. Higher total scores on subjective well-being after the program were significantly associated with having less severe negative symptoms and higher total subjective well-being before the program, and with more positive attitudes toward drugs after the program. These results suggest that intervention with a focus on improving subjective well-being can be an effective part of psychoeducation programs for patients with schizophrenia. The results also suggest that the level of improvement in subjective well-being gained from the program may be higher in patients with milder negative symptoms and patients with a better understanding of drug treatment.
Literature
1.
go back to reference Hornung WP, Kieserg A, Feldmann R, Buchkremer G. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns. 1996;29(3):257–68.CrossRef Hornung WP, Kieserg A, Feldmann R, Buchkremer G. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns. 1996;29(3):257–68.CrossRef
2.
go back to reference Gaebel W. Towards the improvement of compliance: the significance of psychoeducation and new antipsychotic drugs. Int Clin Psychopharmacol. 1997;12(Suppl 1):S37–42.CrossRef Gaebel W. Towards the improvement of compliance: the significance of psychoeducation and new antipsychotic drugs. Int Clin Psychopharmacol. 1997;12(Suppl 1):S37–42.CrossRef
5.
go back to reference Hellewell JS. Patients’ subjective experiences of antipsychotics: clinical relevance. CNS Drugs. 2002;16(7):457–71.CrossRef Hellewell JS. Patients’ subjective experiences of antipsychotics: clinical relevance. CNS Drugs. 2002;16(7):457–71.CrossRef
6.
go back to reference Karow A, Naber D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology(Berl). 2002;162(1):3–10.CrossRef Karow A, Naber D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology(Berl). 2002;162(1):3–10.CrossRef
7.
go back to reference Revicki DA. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence. Curr Opin Investig Drugs. 2001;2(1):110–7.PubMed Revicki DA. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence. Curr Opin Investig Drugs. 2001;2(1):110–7.PubMed
8.
go back to reference Bechdolf A, Knost B, Kuntermann C, Schiller S, Klosterkötter J, Hambrecht M, et al. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr Scand. 2004;110(1):21–8.CrossRef Bechdolf A, Knost B, Kuntermann C, Schiller S, Klosterkötter J, Hambrecht M, et al. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr Scand. 2004;110(1):21–8.CrossRef
9.
go back to reference Herz MI, Lamberti JS, Mintz J, Scott R, O’Dell SP, McCartan L, et al. A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry. 2000;57(3):277–83.CrossRef Herz MI, Lamberti JS, Mintz J, Scott R, O’Dell SP, McCartan L, et al. A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry. 2000;57(3):277–83.CrossRef
10.
go back to reference Aguglia E, Pascolo-Fabrici E, Bertossi F, Bassi M. Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network. Clin Pract Epidemiol Ment Health. 2007;3(7):1–12. Aguglia E, Pascolo-Fabrici E, Bertossi F, Bassi M. Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network. Clin Pract Epidemiol Ment Health. 2007;3(7):1–12.
11.
go back to reference Holmes H, Ziemba J, Evans T, Williams CA. Nursing model of psychoeducation for the seriously mentally ill patient. Issues Ment Health Nurs. 1994;15(1):85–104.CrossRef Holmes H, Ziemba J, Evans T, Williams CA. Nursing model of psychoeducation for the seriously mentally ill patient. Issues Ment Health Nurs. 1994;15(1):85–104.CrossRef
12.
go back to reference Hornung WP, Klingberg S, Feldmann R, Schonauer K, Schulze MH. Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand. 1998;97:213–9.CrossRef Hornung WP, Klingberg S, Feldmann R, Schonauer K, Schulze MH. Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand. 1998;97:213–9.CrossRef
13.
go back to reference Feldmann R, Hornung WP, Prein B, Buchkremer G, Arolt V. Timing of psychoeducational psychotherapeutic interventions in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 2002;252(3):115–9.CrossRef Feldmann R, Hornung WP, Prein B, Buchkremer G, Arolt V. Timing of psychoeducational psychotherapeutic interventions in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 2002;252(3):115–9.CrossRef
14.
go back to reference Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, et al. Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr Res. 2001;50:79–88.CrossRef Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, et al. Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr Res. 2001;50:79–88.CrossRef
15.
go back to reference Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995;10(suppl 3):133–8.PubMed Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995;10(suppl 3):133–8.PubMed
16.
go back to reference Watanabe M, Matsumura H. Reliability and validity of subjective well-being under neuroleptic drug treatment short form, Japanese version (SWNS-J). Jpn J Clin Psychopharmacol. 2003;6:905–12. Watanabe M, Matsumura H. Reliability and validity of subjective well-being under neuroleptic drug treatment short form, Japanese version (SWNS-J). Jpn J Clin Psychopharmacol. 2003;6:905–12.
17.
go back to reference Hogan TTP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative ability. Psychol Med. 1983;13:177–83.CrossRef Hogan TTP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative ability. Psychol Med. 1983;13:177–83.CrossRef
18.
go back to reference Miyata R, Fujii Y, Inagaki A. Medical treatment and quality of life of the schizophrenic patients (part 1). A study of the stance for medicine by the questionnaire (drug attitude inventory, Japanese version). Psychiat Neurol Jap. 1996;98:1045–6. Miyata R, Fujii Y, Inagaki A. Medical treatment and quality of life of the schizophrenic patients (part 1). A study of the stance for medicine by the questionnaire (drug attitude inventory, Japanese version). Psychiat Neurol Jap. 1996;98:1045–6.
19.
go back to reference Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–76.CrossRef Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–76.CrossRef
20.
go back to reference Kay SR, Opler LA. Fiszbein a (translated from English by Yamada H, Masui K, Kikumoto K). Positive and Negative Syndrome Scale (PANSS) rating manual. Tokyo: Seiwa Shoten Publishers; 1991. Kay SR, Opler LA. Fiszbein a (translated from English by Yamada H, Masui K, Kikumoto K). Positive and Negative Syndrome Scale (PANSS) rating manual. Tokyo: Seiwa Shoten Publishers; 1991.
21.
go back to reference Lambert M, Schimmelmann BG, Karow A, Naber D. Subjective well-being and initial dysphoric reaction under antipsychotic drugs – concepts, measurement and clinical relevance. Pharmacopsychiatry. 2003;36(Suppl 3):S181–90.PubMed Lambert M, Schimmelmann BG, Karow A, Naber D. Subjective well-being and initial dysphoric reaction under antipsychotic drugs – concepts, measurement and clinical relevance. Pharmacopsychiatry. 2003;36(Suppl 3):S181–90.PubMed
Metadata
Title
Effects of a Psychoeducation Program for People with Schizophrenia Aimed at Increasing Subjective Well-Being and the Factors Influencing Those Effects: a Preliminary Study
Authors
Ayumi Shinozaki
Teruo Hayashi
Hitoshi Okamura
Publication date
01-03-2020
Publisher
Springer US
Keyword
Schizophrenia
Published in
Psychiatric Quarterly / Issue 1/2020
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-019-09679-4

Other articles of this Issue 1/2020

Psychiatric Quarterly 1/2020 Go to the issue